Abstract:Objective: There is limited information on seizures in patients with idiopathic hypoparathyroidism (IH). We assessed seizure characteristics at presentation, subclinical seizures during follow-up, and the effect of antiepileptic drug (AED) withdrawal in IH patients. Designs and methods: Seizure characteristics were assessed in 70 patients with IH attending endocrine clinic. Provoked electroencephalography (EEG) was performed for subclinical seizures in 44 of them. AEDs were withdrawn using strict criteria, i.e… Show more
“…Treatment of these diseases must focus on calcium supplementation and not on the invalid AED therapy. Our results are consistent with the study of Modi et al [10], who indicated that patients with hypoparathyroidism could reach optimal seizure outcomes regardless of the use of AEDs. Although adult patients were included in their study, patients with seizures as the first manifestation were mainly in their childhood; this trend was similar among our included patients.…”
ObjectivePatients with hypoparathyroidism exhibit metabolic disorders (hypocalcemia) and brain structural abnormalities (brain calcifications). Currently, studies have determined whether antiepileptic drug (AED) treatment is required for epileptic seizures in children with hypoparathyroidism.MethodThis study aims to evaluate the data of two medical centers in Beijing based on the diagnosis of epileptic seizures as the first symptom of hypoparathyroidism in children.ResultA total of 42 patients were included and assigned into AED and non-AED treatment groups in a 1:2 matched case–control study. Results show that the seizure outcome after 1 year of AED treatment is not significantly different from that of the control. In the subgroup analysis of patients with subcortical calcifications, the seizure outcome is still not significantly different from that of the control.ConclusionThus, AED treatment cannot improve the seizure outcomes in children with parathyroid disorder, even in such cases as suspected structural seizure caused by subcortical calcifications. Clinicians must take adequate considerations on the use of AEDs in these patients. Epileptic seizures, as the first symptom of hypoparathyroidism in children, do not require epilepsy drugs.
“…Treatment of these diseases must focus on calcium supplementation and not on the invalid AED therapy. Our results are consistent with the study of Modi et al [10], who indicated that patients with hypoparathyroidism could reach optimal seizure outcomes regardless of the use of AEDs. Although adult patients were included in their study, patients with seizures as the first manifestation were mainly in their childhood; this trend was similar among our included patients.…”
ObjectivePatients with hypoparathyroidism exhibit metabolic disorders (hypocalcemia) and brain structural abnormalities (brain calcifications). Currently, studies have determined whether antiepileptic drug (AED) treatment is required for epileptic seizures in children with hypoparathyroidism.MethodThis study aims to evaluate the data of two medical centers in Beijing based on the diagnosis of epileptic seizures as the first symptom of hypoparathyroidism in children.ResultA total of 42 patients were included and assigned into AED and non-AED treatment groups in a 1:2 matched case–control study. Results show that the seizure outcome after 1 year of AED treatment is not significantly different from that of the control. In the subgroup analysis of patients with subcortical calcifications, the seizure outcome is still not significantly different from that of the control.ConclusionThus, AED treatment cannot improve the seizure outcomes in children with parathyroid disorder, even in such cases as suspected structural seizure caused by subcortical calcifications. Clinicians must take adequate considerations on the use of AEDs in these patients. Epileptic seizures, as the first symptom of hypoparathyroidism in children, do not require epilepsy drugs.
“…The results of the present study include descriptions of the prevalence of chronic complications in the Asian PHP population. Cataracts and intracranial calcification are common chronic complications of hypoparathyroidism and have been observed in 75%‐97.7% and 60%‐70%, respectively, of idiopathic hypoparathyroidism patients. These complications are related to duration of disease and Ca/P ratio .…”
This study is the largest single-centre series of PHP patients and summarizes the clinical and genetic features of the Chinese PHP population. While there was substantial clinical overlap between PHP1A/C and PHP1B, differences in disease progression were observed.
“…The diagnosis of IH was based on hypocalcaemia, hyperphosphataemia and low intact parathyroid hormone (iPTH). 1,7,8 None of the study patients had mutation of the calcium sensing receptor (CASR) or PTH gene. However, GCM2 (R110W) mutation was present in two of them.…”
Section: Methodsmentioning
confidence: 99%
“…The clinical and biochemical features of the cohort and their daily calcium carbonate (1-2 gm of elemental calcium) and 1,a-(OH)D (0Á5-2Á0 lg) therapy were similar to that reported earlier. 1,7,8 Details of cognitive, psychiatric and neurological assessment and abnormalities observed in 27 of 35 study subjects were reported recently. 6 The procedure adopted for assessment of other subjects was essentially the same as described earlier 6 and is briefly given in the supplement information (Please see Data S1).…”
Section: Methodsmentioning
confidence: 99%
“…Serum iPTH was measured using IRMA till 2006 (DiaSorin; NR: 13-54 ng/l) and subsequently by chemiluminescence (Elecsys-2010, Roche; NR: 15-65 ng/l) in the endocrine service laboratory as reported earlier. 1,8 Statistical analysis…”
BGC was associated with modest reduction (15%) in (18) F-FDG uptake at basal ganglia in IH but did not affect dopaminergic function. (18) F-FDG uptake did not correlate with neuropsychological dysfunctions. Interestingly, chronic hypocalcaemia-hyperphosphataemia also contributed to reduction in (18) F-FDG uptake which was independent of BGC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.